期刊文献+

肝素治疗反复妊娠丢失伴抗磷脂抗体阳性孕妇的疗效观察 被引量:1

Study of heparin on pregnant woman with recurrent pregnant loss and positive anti-phospholipid antibody
下载PDF
导出
摘要 目的探讨肝素治疗因抗磷脂抗体所致反复性妊娠丢失及对孕妇血液中抗体的影响。方法记录门诊接诊的狼疮抗凝抗体(LA)和/或抗心磷脂抗体(ACA)阳性的反复性妊娠丢失患者(排除遗传、感染、内分泌及子宫附件异常等可导致流产的因素),选取54例再次妊娠患者,前瞻性的随机分为两组,各27例,分别予肝素(肝素组)和强的松加小剂量阿司匹林(对照组)治疗,观察比较两组的妊娠结局和治疗后LA和ACA的量。结果肝素组27例,足月产27例,早产4例,流产2例,活产率92.6%,抗体清除率71.4%。对照组27例,足月产13例,早产8例,流产6例,活产率77.8%,抗体清除率35.7%。活产率差异无显著性(P>0.05),抗体清除率差异有统计学意义(P<0.01)。结论肝素对抗磷脂抗体所致的反复妊娠丢失治疗效果肯定,并能有效清除抗磷脂抗体。 Objective To evaluate the effect of heparin on women with recurrent pregnant loss with positive anti-phospholipid antibody and its influence on these antibodies serum level.Methods fifty-seven patients with recurrent pregnancy loss were randomized to receive aspirin and prednisone(control group) and heparin(study group).Those caused by other factors such as heredity,infection,endocrine system and uterus and appendixes but with positive lupus anticoagulant(LA) or/and anti-cardiolipin antibodies(ACA) were excluded.Pregnant outcome and the level of LA and ACA before and after medication were observed.Results In study group,21 delivered at full term,4 premature births,2 abortion.The rate of live birth was92.6% with no difference to that of control group[77.8%(P0.05)].The rate of antibody elimination(71.4%)was significantly higher than that of control group[35.7(P0.01)].Conclusion Heparin is effective in managing recurrent pregnant loss due to positive anti-phospholipid antibodies and reducing serum antibody level.
作者 郭丽娟
出处 《中国实用医药》 2013年第13期57-59,共3页 China Practical Medicine
关键词 肝素 妊娠结局 抗磷脂抗体 Heparin Pregnancy outcome Anti-phospholipid antibody
  • 相关文献

参考文献14

  • 1毛立群 ,杨静 ,闫燕华 .抗磷脂抗体与妊娠丢失的研究进展[J].医学综述,2004,10(6):379-380. 被引量:4
  • 2王艳玲,吴华香.抗磷脂综合征与妊娠丢失的研究进展[J].中国妇幼健康研究,2007,18(1):44-46. 被引量:8
  • 3Holmgren C, Aagaard K M, Rice J, et al. Association between an- tiphospholipid antibodies and recurrent early miscarriage-Does a syndrome actually exist. Reproductive Immunology, 2006, 71 (2): 154.
  • 4Sebire N J, Fox H, Baekos M, et al. Defective endovaseular tmpho- blast invasion in primary antiphospholipid antibody syndromeassoci- ated early pregnaney failure. Hum Reprod, 2002, 17 ( 4 ) : 1067-1071.
  • 5Pavan L, Tsatsaris V, Hermouet A, Tbereud P, Evain-Brion D, Fournier T. Oxidized low-density lipopreteins inhibit trophoblastie cell invasion. J Clin Endocrinol Metab, 2004, 89:1969-72.
  • 6di Simone N, Meroni PL, Del Papa N, Rasehi E, Caliandro D, De Carolis S, et al. Antiphospholipid antibodies affect trophoblast gona- dotropin secretion and invasiveness by binding directly and through adhered beta2-glyeoprotein I. Arthritis Rheum, 2000, 43: 140-150.
  • 7Giradi G, Berman J, Redeeha P, et al. Complement C5a receptors and neutmphils mediate let al injury in the antiphospholipid syn- drome. J Clin Invest, 2003, 112:1644-54.
  • 8Meroni PL, DI Simone N, Testoni C, D'Asta M, ACAia B, Caruso A. Antiphospholipid antibodies as cause of pregnancy loss. Lupus, 2004,13(9) :649-52.
  • 9李萍,朱付凡.抗磷脂抗体对妊娠的影响[J].中国优生与遗传杂志,2007,15(3):115-117. 被引量:6
  • 10敖文,杨程德.抗磷脂综合征病理妊娠的机制和治疗进展[J].上海医学,2009,32(12):1132-1135. 被引量:4

二级参考文献80

  • 1杨程德,Pojen P,Chen.抗凝血相关因子抗体检测方法的建立及临床应用[J].诊断学理论与实践,2004,3(4):243-245. 被引量:1
  • 2钱捷,李树杰,陈晓翔,王元,顾越英,鲍春德,陈顺乐,杨程德.凝血相关因子抗体与抗磷脂综合征和血栓相关性研究[J].上海医学,2007,30(3):161-164. 被引量:4
  • 3Amengual 0, Atsumi T, Kharnashta MA, et 02. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome[J].Thromb Haemost, 1998,79 ( 2 ) : 276-281.
  • 4Franklin RD, Hollier N, Kutteh WH. Beta 2-Glycoptoteln 1 as a marker of antiphospholipid syndrome in women with recurrent pregnancy loss[J]. Fertil Steril,2000,73(3) :531-535.
  • 5Rand JH. Antiphospholipid antibody syndrome : new insights on thrombogenic mechanisms[J]. Am J Med Sci, 1998,316(2) : 142-151.
  • 6Sugi T, Makino T. Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy[ J]. J Reprod Immunol,2000,47(2) : 169-184.
  • 7Gharavi AE, Pierangeli SS, Colden SM, et al. GDKV-induced antiphos-pholipid antibodies enhance thrombosis and activate endothelial cells in vivo and in vitro[J] .J Immunol, 1999,163(5) :2922-2927.
  • 8Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome[J]. Med Clin Am, 1997,81(1) : 151-177.
  • 9Durrani OM, Gordon C, Murray PI. Primary anti-phospholipid antibody syndrome(APS) : current concepts[J]. Surv Ophthalmol, 2002,47 (3) :215-238.
  • 10MacLean MA,Cumming GP, McCall F, et al. The prevalence of lupus anticoagulant and anticardiolipin antibodies in women with a history of first trimester miscarriages [ J ]. Br J Obstet Gynaecol, 1994, 101 (2) :103-106.

共引文献16

同被引文献12

引证文献1

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部